Charlotte, North Carolina-based Albemarle Corporation (ALB) develops, manufactures, and markets engineered specialty chemicals for mobility, energy, connectivity, and health solutions. With a market cap of $11.5 billion, the company offers critical ingredients used in grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical devices. The lithium giant is expected to announce its fiscal fourth-quarter earnings for 2024 after the market closes on Wednesday, Feb. 12.
Ahead of the event, analysts expect ALB to report a loss of $0.36 per share on a diluted basis, down 119.5% from $1.85 per share in the year-ago quarter. The company missed the consensus estimates in three of the last four quarters while beating the forecast on another occasion.
